JASON BRIGNAC: Open Payments
NPI 1154935146 · HUNTSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 32 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $16 · 2025 $934
Food & beverage: $744Education: $190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $382 |
| Sumitomo Pharma America, Inc. | 8 | $144 |
| Astellas Pharma US Inc | 2 | $122 |
| Antares Pharma, Inc. | 5 | $86 |
| Dendreon Pharmaceuticals LLC | 2 | $45 |
| Teleflex LLC | 1 | $36 |
| ABBVIE INC. | 2 | $33 |
| Ferring Pharmaceuticals Inc. | 1 | $29 |
| Endo USA, Inc. | 1 | $23 |
| Boston Scientific Corporation | 1 | $17 |
Products named: RYBREVANT, ERLEADA, GEMTESA, XYOSTED, PROVENGE, UROLIFT, LUPRON DEPOT, ADSTILADRIN.
Industry payments across TX — which companies pay providers there.
